Scientists have observed that a drug which is already approved to treat several blood cancers, is associated with reduced respiratory distress and a reduction in the overactive immune response in Covid-19 patients, an advance that may lead to a potential therapeutic for novel coronavirus infection.

from Science News - Times of India https://ift.tt/374wOjs